COMBINATION THERAPY FOR NON-SMALL CELL LUNG CANCER POSITIVE FOR EGFR MUTATION

• 收藏
• 分享

专利权人:

MEDIMMUNE LIMITED

发明人:

DAR, Mohammed, M,KARAKUNNEL, Joyson, J,JIANG, Haiyi,KIRKBY, Maxwell, J

申请号：

SG11201708556S

公开号：

SG11201708556SA

申请日:

2016.04.22

申请国别(地区):

SG

年份:

2017

代理人:

摘要：

The present invention features methods of treating lung cancer (e.g., NSCLC) with an anti-PD-L1 antibody and a tyrosine kinase inhibitor in a subject identified as having an EGFR mutation-positive tumor.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/